Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development) [Hardcover]

Beverly A. Teicher (Editor)

Book Description

Publication Date: January 15, 1999 | ISBN-10: 0896036413 | ISBN-13: 978-0896036413 | Edition: 1st

Beverly Teicher and a panel of distinguished investigators survey the state-of-the-art of antiangiogenesis research from the lab bench to clinical trials. Timely and authoritative, the contributors summarize our current understanding of tumor growth and its dependence on vascular development, as well as the present status of antiangiogenic agents in preclinical and clinical development. In addition, the book also examines what is known about the mechanisms by which these therapeutic agents interfere with tumor vasculature and grapples with the problem of establishing criteria by which to assess their clinical efficacy. Antiangiogenic Agents in Cancer Therapy offers a unique cutting-edge compendium of antiangiogenic research, taking stock of what has been accomplished , where the experimental therapeutics of antiangiogenic agents is going, and the continuing evolution of their role in cancer treatment and novel drug development.

Editorial Reviews

Review

From the reviews of the second edition:

"This is a second edition of a well-accepted text on angiogenesis and antiangiogenic agents, particularly on their use in cancer therapy. In addition to the editors, a large number of outstanding investigators have contributed to this book. … This edition is highly recommended to all of those involved in research or the clinical practice of oncology." (Julian L. Ambrus and Clara M. Ambrus, The Journal of Medicine, March, 2008)

--This text refers to an alternate Hardcover edition.

From the Back Cover

Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge. Antiangiogenic Agents in Cancer Therapy, Second Edition provides a current, up-dated perspective on the state of the art of angiogenesis and therapy with a compendium of scientific findings and approaches to the study of angiogenesis in cancer.  Leaders in the field present chapters on such topics as the environmental influences and the genetic and physiologic abnormalities that mediate angiogenesis and its role in the progression of malignant disease, working models of tumor angiogenesis, and the role of angiogenesis inhibition in the therapy of malignant disease in humans.  Comprehensive and cutting-edge, Antiangiogenic Agents in Cancer Therapy, Second Edition is an ideal, valuable guide to the most recent advances in the field, and a collection that will be useful for many years to come. --This text refers to an alternate Hardcover edition.

Product Details

• Hardcover: 450 pages
• Publisher: Humana Press; 1st edition (January 15, 1999)
• Language: English
• ISBN-10: 0896036413
• ISBN-13: 978-0896036413
• Product Dimensions: 10.2 x 7.3 x 1.1 inches
• Shipping Weight: 2.6 pounds (View shipping rates and policies)
• Amazon Best Sellers Rank: #6,488,660 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.